Washington University Taylor Family Institute for Innovative Psychiatric Research-Originated Drug in Clinical Trials for Major Depression

Washington University Taylor Family Institute for Innovative Psychiatric Research-Originated Drug in Clinical Trials for Major Depression

33% of 14 million American’s suffering from clinical depression get no relief from today’s approved antidepressant drugs.  A new treatment approach involving neurosteroids is on the horizon however that may be more effective. The strategy of using neurosteroids was...
Florey Institute of Neuroscience & Mental Health Commences World’s First Alcohol Use Disorder Clinical Trial

Florey Institute of Neuroscience & Mental Health Commences World’s First Alcohol Use Disorder Clinical Trial

The Florey Institute of Neuroscience and Mental Health and St. Vincent’s Hospital in Melbourne, Australia, have commenced a world-first clinical study to test the treatment of Belsomra (Suvorexant) in 128 participants with co-occurring insomnia and alcohol use...
Privately-Held Segal Trials Supports Usona Institute’s PSIL201 Clinical Trial Testing the Use of Psilocybin for Major Depression

Privately-Held Segal Trials Supports Usona Institute’s PSIL201 Clinical Trial Testing the Use of Psilocybin for Major Depression

Segal Trials, a privately held network of research sites throughout South Florida and South Carolina conducting Phase I-IV clinical trials, has been named one of seven sites to initiate a Phase II study of psilocybin—a psychedelic prodrug compound—for major depressive...

Pin It on Pinterest